View all blogs:
Croda welcomes Thomas Riermeier as new President of Life Sciences
Pharma
Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that Dr. Thomas Riermeier has been appointed as the new...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=4F9521E2A9CDAB872D1AA12B9BA9F4EB)
From Lab to Patient: Optimising Oncology Formulations with Purified Excipients
Pharma
In 2024, we hosted a live webinar exploring the impact of our Super RefinedTM excipients on various chemotherapeutic formulations. This blog will explore some of the key learnings from the webinar.
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=F330DFD631D5F6E81578038D37E005ED){kind=logo}
Croda’s Avanti Research expands ionizable lipid offering for LNP drug development through Certest collaboration
Pharma
Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and Certest Biotec S.L. (Certest) are pleased to announce a strategic collaboration to expand the market’s access to...
Protein Leader: Garima Sinha
Pharma
In our latest edition of Protein Leaders, we speak to Garima Sinha. Keep reading to learn more...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=1A76ADAC46124CA8DF3A96C10265D3C2)
Heart Health month
Pharma
February marks Heart Month, this global initiative looks to educate the population on heart disease and what preventative measures can be taken to improve cardiovascular health. In this blog, we...
Plant cholesterol – The future of lipid-based drug delivery
Pharma
While cholesterol is undeniably a key player in lipid formulations, effective across various dosage routes and genetic delivery applications, an important question remains: does the source of...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A64095A181C3A54A0679D38F67C4CA0E)
Lipids Leader: Rasmus Münter, PhD - Lead Research Scientist
Pharma
In our latest edition of Lipid Leaders, we speak to Rasmus Münter, PhD. Rasmus is a lipid-based nanoparticle and vaccine adjuvant expert based in Denmark for Croda Pharma. Keep reading to learn more...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=51D19B4B65B031475D93DBD45F1F23DC)
Insights into the veterinary health market
Pharma
The veterinary market in the EMEA region is expected to experience substantial growth in the coming years: 5-8% CAGR. Typically, the veterinary market is categorised into companion animals and...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=D964AC649BA30C623822E347ADA7FD18)
World Cancer Day 2025
Pharma
In 2022 alone, 9.7 million people worldwide lost their lives to cancer, and the number of new cases is expected to rise to nearly 30 million by 2040. It is a disease that takes so much from so many,...
Croda opens advanced lipids manufacturing facility in Pennsylvania
Pharma
PRESS RELEASE: 15 January 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, today announces the...
New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark
Pharma
PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...
Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture
Pharma
Croda Pharma has announced the launch of Super Refined™ Poloxamer 188, an innovative bioprocessing solution developed to meet the increasing demands of biopharmaceutical development.
Announcing Avanti Research - a Croda brand
Pharma
Avanti Polar Lipids, a global leader in lipids, has announced its renewed offering for researchers and its transformation to Avanti Research.
The Oral Hygiene market is evolving
Pharma
Growth in the oral hygiene market is mainly focused around two main categories: toothpastes and mouthwashes. The global oral hygiene market size was valued at USD 31.7 billion in 2020 and is expected...
EXCLUSIVE WHITEPAPER: Next-generation Triton™ X-100 replacements for pharmaceutical bioprocessing
Pharma
Triton™ X-100 (tert-octyl phenyl ethoxylate) is used extensively in the manufacture of biologics, plasma-derived products and cell and gene therapies (CGTs). This non-ionic detergent is used because...
Veterinary vaccines - solutions for an ongoing challenge...
Pharma
Growth in the veterinary pharmaceutical industry continues to be driven by increasing pet ownership globally and the rising demand for veterinary vaccines to prevent the risk of zoonotic diseases in...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A3F1E1F41A1C690A537D793D09D9F2EA)
QbD Formulation Development
Pharma
Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A303EDE921EF0283547DD585579EDC71)
Targeted lipid nanoparticles in Nucleic Acid Delivery
Pharma
Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
Croda joins CGT Catapult consortium to improve AAV formulation
Pharma
The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.